investor login
contact
team
dedicated funds
news
portfolio
Portfolio Company News
Search for:
Sarepta pays StrideBio $48M for preclinical gene therapies
Portfolio Company News
NextGen Healthcare Announces Agreement to Acquire Medfusion, Inc.
Portfolio Company News
Clearside Biomedical Announces Option Exercise by REGENXBIO for Global License for Use of SCS Microinjector™ in AAV Gene Therapy Delivery
Portfolio Company News
410 Medical Secures $8 Million in Series A Financing, Expands Board of Directors
Portfolio Company News
Qpex Biopharma and Brii Biosciences Enter Into a Strategic Collaboration to Develop and Commercialize Antibiotics for Drug-Resistant Infections in China
Portfolio Company News
A twisty career path to improve care for smokers
Portfolio Company News
Graybug Vision Initiates Phase 2b (ALTISSIMO) Clinical Trial of GB-102 in Patients with Wet Age-Related Macular Degeneration
Portfolio Company News
VERTEX AND RIBOMETRIX ESTABLISH STRATEGIC COLLABORATION TO DISCOVER AND DEVELOP RNA-TARGETED SMALL MOLECULE THERAPEUTICS
Portfolio Company News
Graybug Vision Initiates Clinical Trial in Macular Edema Secondary to Diabetic Macular Edema or Retinal Vein Occlusion
Portfolio Company News
Graybug Vision Secures $80 million of Additional Funding to Advance its Potentially Transformative Retina and Glaucoma Clinical Programs
Portfolio Company News
GeneCentric Therapeutics Acquires Select ImmunoGenomics
Portfolio Company News
Trefoil Therapeutics Raises $28 Million Series A to Advance Engineered FGF-1 for the Treatment of Corneal Diseases
Portfolio Company News
Older Posts >
< Newer Posts
contact
team
dedicated funds
news
home
portfolio
